Ginnie Clark

[Alzheimer's Society @alzheimerssoc]

A simple blood test could help change the future of dementia diagnosis.

The Blood Biomarker Challenge is a ground-breaking research initiative which aims to bring blood tests for dementia diagnosis into the NHS by 2030.

Dementia is the leading cause of death in the UK, yet over a third of people living with the condition remain undiagnosed - meaning they can’t access the treatment, care, and support they urgently need.

These blood tests could offer a less invasive and more accessible way to help identify the diseases that cause dementia, helping more people get the early and accurate diagnosis they deserve.

This would give more families the chance to plan for the future, access appropriate treatments and support, and take part in research. In due course, these tests are likely to be needed to access emerging treatments that may slow the progression of dementia.

Watch our video to find out more about how these blood tests work, and the difference they could make.

The Blood Biomarker Challenge is supported by Alzheimer’s Society, @AlzResearchUK, @NIHRresearch, Gates Ventures and @PostcodeLottery players.